×

Once registered, you can:

  • - Read additional free articles each month
  • - Comment on articles and featured creative work
  • - Get our curated newsletters delivered to your inbox

By registering you agree to our privacy policy, terms & conditions and to receive occasional emails from Ad Age. You may unsubscribe at any time.

Are you a print subscriber? Activate your account.

Glaxo moves Imitrex planning

Published on .

Glaxo Wellcome, Research Triangle Park, N.C., moved traditional and new-media planning for its $37 million Imitrex direct-to-consumer prescription migraine drug account to Wilson Media Group from Klemtner Advertising, both New York. Media Edge, New York, continues to handle buying.

Copyright May 1998, Crain Communications Inc.

Most Popular
In this article: